[go: up one dir, main page]

WO2006110735A3 - Genotyping hla loci - Google Patents

Genotyping hla loci Download PDF

Info

Publication number
WO2006110735A3
WO2006110735A3 PCT/US2006/013462 US2006013462W WO2006110735A3 WO 2006110735 A3 WO2006110735 A3 WO 2006110735A3 US 2006013462 W US2006013462 W US 2006013462W WO 2006110735 A3 WO2006110735 A3 WO 2006110735A3
Authority
WO
WIPO (PCT)
Prior art keywords
hla loci
genotyping
genotyping hla
loci
pcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/013462
Other languages
French (fr)
Other versions
WO2006110735A2 (en
Inventor
Zachary Antovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linkage Biosciences Inc
Original Assignee
Linkage Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linkage Biosciences Inc filed Critical Linkage Biosciences Inc
Priority to US11/910,465 priority Critical patent/US20080182252A1/en
Priority to EP06740852A priority patent/EP1871906B8/en
Priority to ES06740852T priority patent/ES2394097T3/en
Priority to CA2603605A priority patent/CA2603605C/en
Publication of WO2006110735A2 publication Critical patent/WO2006110735A2/en
Anticipated expiration legal-status Critical
Publication of WO2006110735A3 publication Critical patent/WO2006110735A3/en
Priority to US13/160,247 priority patent/US20110250605A1/en
Priority to US13/562,004 priority patent/US20120295271A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)

Abstract

This invention provides for an improved method for genotyping HLA loci using PCR.
PCT/US2006/013462 2005-04-08 2006-04-07 Genotyping hla loci Ceased WO2006110735A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/910,465 US20080182252A1 (en) 2005-04-08 2006-04-07 Genotyping Hla Loci
EP06740852A EP1871906B8 (en) 2005-04-08 2006-04-07 Genotyping hla loci
ES06740852T ES2394097T3 (en) 2005-04-08 2006-04-07 Genotyping of HLA loci
CA2603605A CA2603605C (en) 2005-04-08 2006-04-07 Genotyping hla loci
US13/160,247 US20110250605A1 (en) 2005-04-08 2011-06-14 Genotyping hla loci
US13/562,004 US20120295271A1 (en) 2005-04-08 2012-07-30 Genotyping hla loci

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66976005P 2005-04-08 2005-04-08
US60/669,760 2005-04-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/160,247 Continuation US20110250605A1 (en) 2005-04-08 2011-06-14 Genotyping hla loci

Publications (2)

Publication Number Publication Date
WO2006110735A2 WO2006110735A2 (en) 2006-10-19
WO2006110735A3 true WO2006110735A3 (en) 2007-12-13

Family

ID=37087631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/013462 Ceased WO2006110735A2 (en) 2005-04-08 2006-04-07 Genotyping hla loci

Country Status (5)

Country Link
US (3) US20080182252A1 (en)
EP (1) EP1871906B8 (en)
CA (1) CA2603605C (en)
ES (1) ES2394097T3 (en)
WO (1) WO2006110735A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585974B1 (en) 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
EP2166470A1 (en) * 2008-09-19 2010-03-24 Corbett Research Pty Ltd Analysis of melt curves, particularly dsDNA and protein melt curves
US9422597B2 (en) 2008-11-07 2016-08-23 Biofire Diagnostics, Inc. Allele amplification bias
CA2748265C (en) * 2008-12-22 2018-04-03 University Of Utah Research Foundation Monochrome multiplex quantitative pcr
JP6546158B2 (en) 2013-05-22 2019-07-17 テロメア ダイアグノスティクス インコーポレイテッド Measurement of short telomere abundance
DK3533882T3 (en) * 2013-10-15 2022-12-19 Illumina Inc SINGLE NUCLEOTIDE POLYMORPHISM IN MAJOR HISTOCOMPATIBILITY COMPLEX
EP3240910B1 (en) 2014-12-30 2020-11-18 Telomere Diagnostics, Inc. Multiplex quantitative pcr
AR105291A1 (en) * 2015-07-10 2017-09-20 Bayer Sas METHODS AND SETS OF ELEMENTS FOR THE DETECTION OF THE EARTH
CN113564240B (en) * 2021-05-31 2024-07-19 德必碁生物科技（厦门）有限公司 HLA-B27 allele detection method and detection kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002073A1 (en) * 2001-10-15 2004-01-01 Li Alice Xiang Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670124B1 (en) * 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002073A1 (en) * 2001-10-15 2004-01-01 Li Alice Xiang Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FUKUSHIMA ET AL.: "Duplex Real Time SYBR Green PCR Assays for Detection of 17 Species of Food or Waterborne Pathogens in Stools", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 41, pages 5314 - 5346, XP002400106 *

Also Published As

Publication number Publication date
WO2006110735A2 (en) 2006-10-19
US20080182252A1 (en) 2008-07-31
CA2603605C (en) 2015-12-15
CA2603605A1 (en) 2006-10-19
ES2394097T3 (en) 2013-01-17
EP1871906B8 (en) 2012-11-21
EP1871906B1 (en) 2012-10-10
US20110250605A1 (en) 2011-10-13
EP1871906A4 (en) 2009-07-22
US20120295271A1 (en) 2012-11-22
EP1871906A2 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
TWI316272B (en) Method for controlling polysilicon removal
WO2009076676A3 (en) Compositions and methods for producing isoprene
MX265618B (en) Method for preparing n-phenylpyrazole-1-carboxamides.
WO2008014008A3 (en) Compositions and methods for modulating angiogenesis
EP1954667A4 (en) Methods for isolating propargylated aminoindans
WO2009052221A3 (en) Methods for extracting platelets and compositions obtained therefrom
GB0414815D0 (en) Method for stabilising reagents which are useful for nucleic acid amplification
WO2006118862A3 (en) Methods for protecting glass
IL217235A0 (en) Compositions for immunizing against mycobacterium
WO2006110735A3 (en) Genotyping hla loci
WO2005074645A3 (en) Methods and compositions for modulating angiogenesis
EG24870A (en) Method for deodorisation
EP1859479B8 (en) Method for microstructuring solid surfaces
GB2419594C (en) Method for stabilizing or isolating nucleic acids.
MX274730B (en) Method for obtaining coating compositions having reduced voc.
GB0413574D0 (en) An invention for power-producing
EP1968953A4 (en) Method for isolating (r)-tofisopam
GB0509381D0 (en) P.C. Tool
WO2007033834A3 (en) Method for the analysis of nucleic acid methylation
AU2004902478A0 (en) Improved Method for DNA Extraction
AU2005906375A0 (en) DNA markers for intramuscular fat
AU2005904425A0 (en) DNA markers for intramuscular fat
AU2005903955A0 (en) DNA markers for intramuscular fat
AU2005903952A0 (en) DNA markers for intramuscular fat
AU2005906376A0 (en) DNA markers for intramuscular fat

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11910465

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2603605

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006740852

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU